The Effectiveness of Colistin/Rifampin Compared to Colistin/Meropenem in the Treatment of Ventilator-associated Pneumonia Caused by Carbapenem-resistant <i>Acinetobacter baumannii</i>: A Randomized Controlled Clinical Trial.

J Res Pharm Pract · 2024 · PMC12017404 · PMID 40275969

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

a decreasing trendno p-value reported

Although the SOFA score in the experimental group showed a decreasing trend during the study, these changes were insignificant.

also in 47,180 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.

The Effectiveness of Colistin/Rifampin Compared to Colistin/Meropenem in the Treatment of Ventilator-associated Pneumonia Caused by Carbapenem-resistant &lt;i&gt;Acinetobacter baumannii&lt;/i&gt;: A Randomized Controlled Clinical Trial.

The sentences

The Effectiveness of Colistin/Rifampin Compared to Colistin/Meropenem in the Treatment of Ventilator-associated Pneumonia Caused by Carbapenem-resistant <i>Acinetobacter baumannii</i>: A Randomized Controlled Clinical Trial.